In a popular television series, a terrorist hacks into the Vice President’s pacemaker software causing it to malfunction and kill him. Is this a real risk, or are we just watching too much television? Well, several government officials are taking … Continue reading →
Anybody who tracks medical device and pharmaceutical FDA recalls knows that these occur with some regularity and that some of the recalls are necessary to prevent serious life threatening injuries. A product recall can be potentially devastating for the product … Continue reading →
In the United States, when a drug or medical device company conducts its human clinical trials at a government-owned facility, it may be stepping back in time where indemnification is concerned. This is because state or federal medical facilities fall … Continue reading →
The new drug and medical device discovery process necessarily requires human clinical trials. Continue reading →
Life science companies face a unique and significant property loss potential that is not covered by a traditional property insurance policy. Continue reading →
Hospitals can benefit from conducting clinical research in their facilities, but failure to identify and handle the risk exposures this research creates can cost millions of dollars. Continue reading →
Outside the U.S., many regulators are requiring trial sponsors to compensate clinical trial participants for injuries sustained during participation in a trial. Continue reading →
No posts by this author.